Sir Andrew Hall

International Agency for Research on Cancer

Sir Andrew J. Hall is a Senior Research Scientist responsible for the GHIS at the International Agency for Research on Cancer in Lyon, France. Sir Hall studied MSc Epidemiology in 1982, and went on to work for the School for 22 years, initially as a senior lecturer and then becoming Professor of Epidemiology 2001. Sir Hall’s contribution to public health has been considerable, with his leading the Gambian trial of hepatitis B vaccine, the first and longest running trial of a vaccine against any cancer, and subsequently demonstrating that adult exposure to children with chickenpox substantially reduces the risk of varicella zoster.

Sir Hall has also contributed to public health policy relating to infectious disease control, serving on the Board of Health Protection Agency during 2002-09 and on the Joint Committee on Vaccines and Immunisation, which had a significant role in the UK’s national vaccination policy. As well as this, he served on the WHO committee reviewing the Global Polio Eradication Initiative and was on the independent review committee of the Global Alliance on Vaccines and immunization.